Details for Patent: 11,759,503

Which drugs does patent 11,759,503 protect, and when does it expire?

Patent 11,759,503 protects RYBELSUS and is included in one NDA.

This patent has thirty-nine patent family members in twenty-four countries.

Drugs Protected by US Patent 11,759,503

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Novo	RYBELSUS	semaglutide	TABLET;ORAL	213051-001	Sep 20, 2019		RX	Yes	No			Y
Novo	RYBELSUS	semaglutide	TABLET;ORAL	213051-002	Sep 20, 2019		RX	Yes	No			Y
Novo	RYBELSUS	semaglutide	TABLET;ORAL	213051-003	Sep 20, 2019		RX	Yes	Yes			Y

International Family Members for US Patent 11,759,503

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2013234496
Australia	2017251814
Brazil	112014023374